Casdin Capital, LLC - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 84 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is 3.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q3 2021$5,923,000
-58.0%
2,575,000
-19.9%
0.15%
-58.9%
Q2 2021$14,116,000
-39.5%
3,215,4340.0%0.36%
-48.5%
Q1 2021$23,344,000
+203.7%
3,215,434
+71.9%
0.70%
+102.0%
Q3 2020$7,686,000
-22.4%
1,870,000
+13.3%
0.34%
-41.3%
Q2 2020$9,900,000
+34.8%
1,650,000
+69.2%
0.59%
-24.8%
Q1 2020$7,342,000
-34.9%
975,000
+18.9%
0.78%
-24.9%
Q4 2019$11,275,000
-99.7%
820,000
+164.5%
1.04%
+172.2%
Q3 2019$3,682,800,000
+163.2%
310,000
+210.0%
0.38%
+190.8%
Q2 2019$1,399,000,000100,0000.13%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q1 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 5,307,751$3,101,0001.18%
TANG CAPITAL MANAGEMENT LLC 2,000,000$1,168,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$4,060,0000.08%
Artal Group S.A. 1,803,858$1,054,0000.06%
GSA CAPITAL PARTNERS LLP 616,402$360,0000.05%
RA Capital Management 3,040,885$1,776,0000.05%
Forefront Analytics, LLC 92,641$58,0000.03%
Temasek Holdings (Private) Ltd 4,319,049$2,523,1880.01%
FEDERATED HERMES, INC. 8,309,859$4,853,0000.01%
Cormorant Asset Management, LP 256,649$150,0000.01%
View complete list of ORCHARD THERAPEUTICS PLC shareholders